mAbxience and Abbott Sign Strategic Agreement to Broaden Access to a Pipeline of Biosimilars in Key Emerging MarketsMiguel Martínez-Cava2023-10-05T16:05:09+02:00September 20, 2023|Press releases|
Single-use technology: how efficient is the present and future of biopharma manufacturing?adriana.polo2024-10-30T16:58:43+01:00October 30, 2024|News|
Overcoming the complex regulatory challenges in biopharmaceuticalsadriana.polo2024-09-30T18:26:06+02:00September 30, 2024|News|
Navigating regulatory landscapes in biopharmaceutical manufacturingadriana.polo2024-09-20T10:36:39+02:00September 20, 2024|News|